Quick Answer
Ensysce Biosciences, Inc. reported Net Income of $2.40 million for fiscal year 2020.
Ensysce Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2020 | $2.40M | +557.1% |
| 2019 | $366.0K | -82.8% |
| 2018 | $2.12M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | -$17.16M | -1192.9% | -1734.6% |
| June 30, 2021 | -$935.5K | -32.8% | +45.3% |
| March 31, 2021 | -$1.71M | -195.5% | -209.0% |
| September 30, 2020 | $1.57M | +220.7% | +322.9% |
| June 30, 2020 | -$704.5K | -268.2% | -139.3% |
| March 31, 2020 | $1.79M | +131.0% | +266.1% |
| September 30, 2019 | $489.7K | -15.2% | +16.9% |
| June 30, 2019 | $418.9K | +0.9% | -46.0% |
- Ensysce Biosciences, Inc. showed an increase of +557.1% in Net Income compared to the prior fiscal year.
- Over the 2018–2020 period, Ensysce Biosciences, Inc.’s net income has grown by 13.3% (from $2.12 million to $2.40 million).
- The most recent figure is from Ensysce Biosciences, Inc.’s fiscal year 2020 report (Form 10-K), filed with the SEC on March 15, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: